PDB57 REAL-WORLD ECONOMIC OUTCOMES AMONG PATIENTS WITH TYPE 2 DIABETES (T2D) TREATED WITH DULAGLUTIDE (DU) VS. BASAL INSULIN (BI) IN THE US: THE DISPELTM STUDY
May 1, 2019, 00:00
10.1016/j.jval.2019.04.606
https://www.valueinhealthjournal.com/article/S1098-3015(19)30798-3/fulltext
Title :
PDB57 REAL-WORLD ECONOMIC OUTCOMES AMONG PATIENTS WITH TYPE 2 DIABETES (T2D) TREATED WITH DULAGLUTIDE (DU) VS. BASAL INSULIN (BI) IN THE US: THE DISPELTM STUDY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30798-3&doi=10.1016/j.jval.2019.04.606
First page :
Section Title :
Open access? :
No
Section Order :
10226